Skip to content

CorMedix CRMD Short-Term Investments

Short-Term Investments at other companies

Pfizer logo
PfizerPFE
$11.37B-28.4%
Merck & Co. logo
Merck & Co.MRK
$375M-37.4%
IAR
Integra LifeSciencesIART
$28.69M-16.1%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$61.35M-6.8%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$3M-81.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$122.27M+290%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's short-term investments?
CorMedix (CRMD) reported short-term investments of $0 in Q1 2026.
How has CorMedix's short-term investments changed year-over-year?
CorMedix's short-term investments decreased by 100.0% year-over-year, from $11.22M to $0.
What is the long-term trend for CorMedix's short-term investments?
Over 5 years (2020 to 2025), CorMedix's short-term investments has grown at a -3.6% compound annual growth rate (CAGR), from $4.44M to $3.69M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.